Mitomo, 2010, Toward gene therapy for cystic fibrosis using a lentivirus pseudotyped with Sendai virus envelopes, Mol. Ther., 18, 1173, 10.1038/mt.2010.13
Walsh, 2003, Gene therapy progress and prospects: gene therapy for the hemophilias, Gene Ther., 10, 999, 10.1038/sj.gt.3302024
McNeish, 2004, Gene therapy progress and prospects: cancer gene therapy using tumour suppressor genes, Gene Ther., 11, 497, 10.1038/sj.gt.3302238
Tuszynski, 2002, Growth-factor gene therapy for neurodegenerative disorders, Lancet Neurol., 1, 51, 10.1016/S1474-4422(02)00006-6
Bunnell, 1998, Gene therapy for infectious diseases, Clin. Microbiol. Rev., 11, 42, 10.1128/CMR.11.1.42
Anderson, 1994, Gene therapy for AIDS, Hum. Gene Ther., 5, 149, 10.1089/hum.1994.5.2-149
Yin, 2014, Non-viral vectors for gene-based therapy, Nat. Rev. Genet., 15, 541, 10.1038/nrg3763
Rytblat, 2016, In vitro studies of polyethyleneimine coated miRNA microspheres as anticancer agents, Nano Res., 1-9
Young, 2006, Viral gene therapy strategies: from basic science to clinical application, J. Pathol., 208, 299, 10.1002/path.1896
Rodriguez, 2015, Tailoring minimalist self-assembling peptides for localized viral vector gene delivery, Nano Res., 9, 674, 10.1007/s12274-015-0946-0
Marshall, 1999, Gene therapy death prompts review of adenovirus vector, Science, 286, 2244, 10.1126/science.286.5448.2244
Kaiser, 2003, Seeking the cause of induced leukemias in X-SCID trial, Science, 299, 495, 10.1126/science.299.5606.495
Glover, 2005, Towards safe, non-viral therapeutic gene expression in humans, Nat. Rev. Genet., 6, 299, 10.1038/nrg1577
Lee, 2005, Polyethylene glycol-conjugated copolymers for plasmid DNA delivery, Pharm. Res., 22, 1, 10.1007/s11095-004-9003-5
Chen, 2013, Self-assembled BolA-like amphiphilic peptides as viral-mimetic gene vectors for cancer cell targeted gene delivery, Macromol. Biosci., 13, 84, 10.1002/mabi.201200283
Nimesh, 2011, Cationic polymer based nanocarriers for delivery of therapeutic nucleic acids, J. Biomed. Nanotechnol., 7, 504, 10.1166/jbn.2011.1313
Wang, 2012, Design of multifunctional non-viral gene vectors to overcome physiological barriers: dilemmas and strategies, Int. J. Pharm., 427, 3, 10.1016/j.ijpharm.2011.07.013
Malaekeh-Nikouei, 2009, Preparation, characterization and transfection efficiency of nanoliposomes modified with oligoamines as gene carrier, Nanomedicine: NBM, 5, 457, 10.1016/j.nano.2009.02.001
Ramezani, 2009, The influence of size, lipid composition and bilayer fluidity of cationic liposomes on the transfection efficiency of nanolipoplexes, Colloids Surf. B: Biointerfaces, 72, 1, 10.1016/j.colsurfb.2009.03.018
Kazemi Oskuee, 2015, Preparation, characterization and transfection efficiency of nanoparticles composed of alkane-modified polyallylamine, Nanomed. J., 2, 111
Patnaik, 2013, Novel polyethylenimine-derived nanoparticles for in vivo gene delivery, Expert Opin. Drug Deliv., 10, 215, 10.1517/17425247.2013.744964
Ewe, 2014, Storage stability of optimal liposome-polyethylenimine complexes (lipopolyplexes) for DNA or siRNA delivery, Acta Biomater., 10, 2663, 10.1016/j.actbio.2014.02.037
Dizaj, 2014, A sight on the current nanoparticle-based gene delivery vectors, Nanoscale Res. Lett., 9, 1, 10.1186/1556-276X-9-252
Gao, 1996, Potentiation of cationic liposome-mediated gene delivery by polycations, Biochem. U.S., 35, 1027, 10.1021/bi952436a
Hanzlíková, 2009, The role of PEI structure and size in the PEI/liposome-mediated synergism of gene transfection, Plasmid, 61, 15, 10.1016/j.plasmid.2008.08.003
Lungwitz, 2005, Polyethylenimine-based non-viral gene delivery systems, Eur. J. Pharm. Biopharm., 60, 247, 10.1016/j.ejpb.2004.11.011
Zhou, 2012, Ultra-small graphene oxide functionalized with polyethylenimine (PEI) for very efficient gene delivery in cell and zebrafish embryos, Nano Res., 5, 703, 10.1007/s12274-012-0254-x
Lampela, 2003, Different synergistic roles of small polyethylenimine and Dosper in gene delivery, J. Control. Release, 88, 173, 10.1016/S0168-3659(02)00489-3
Lampela, 2004, Synergism in gene delivery by small PEIs and three different nonviral vectors, Int. J. Pharm., 270, 175, 10.1016/j.ijpharm.2003.10.004
Matsumoto, 2008, Hybrid vector including polyethylenimine and cationic lipid, DOTMA, for gene delivery, Int. J. Pharm., 363, 58, 10.1016/j.ijpharm.2008.07.010
Gaedtke, 2007, Transcriptionally targeted nonviral gene transfer using a β-catenin/TCF-dependent promoter in a series of different human low passage colon cancer cells, Mol. Pharm., 4, 129, 10.1021/mp0600586
Lee, 2003, Synergistic effect of polyethylenimine and cationic liposomes in nucleic acid delivery to human cancer cells, Biochim. Biophys. Acta, 1611, 55, 10.1016/S0005-2736(03)00027-0
Pelisek, 2006, Optimized lipopolyplex formulations for gene transfer to human colon carcinoma cells under in vitro conditions, J. Gene Med., 8, 186, 10.1002/jgm.836
Penacho, 2009, Polyethylenimine of various molecular weights as adjuvant for transfection mediated by cationic liposomes, Mol. Membr. Biol., 26, 249, 10.1080/09687680902766716
Penacho, 2010, Physicochemical properties of transferrin-associated lipopolyplexes and their role in biological activity, Colloids Surf. B: Biointerfaces, 76, 207, 10.1016/j.colsurfb.2009.10.034
Schäfer, 2010, Liposome–polyethylenimine complexes for enhanced DNA and siRNA delivery, Biomaterials, 31, 6892, 10.1016/j.biomaterials.2010.05.043
García, 2007, Serum-resistant lipopolyplexes for gene delivery to liver tumour cells, Eur. J. Pharm. Biopharm., 67, 58, 10.1016/j.ejpb.2007.01.005
Tros De Ilarduya, 2010, Liposomes and lipopolymeric carriers for gene delivery, J. Microencaps., 27, 602, 10.3109/02652048.2010.501396
Ko, 2012, Liposome-encapsulated polyethylenimine/oligonucleotide polyplexes prepared by reverse-phase evaporation technique, AAPS PharmSciTech, 13, 373, 10.1208/s12249-012-9757-8
Ko, 2009, Liposome encapsulated polyethylenimine/ODN polyplexes for brain targeting, J. Control. Release, 133, 230, 10.1016/j.jconrel.2008.10.013
Ramezani, 2012, The effect of lipopolymer structure on the transfection efficiency of hydrophobic polyethylenimine-based cationic nanoliposomes, Curr. Nanosci., 8, 680, 10.2174/157341312802884535
Ramezani, 2011, The effect of linear PEI on characteristics and transfection efficiency of PEI-based cationic nanoliposomes, Iran, J. Basic Med. Sci., 14, 82
Mahmoudi, 2014, Preparation and in-vitro transfection efficiency evaluation of modified cationic liposome–polyethyleneimine–plasmid nanocomplexes as a novel gene carrier, Curr. Drug Del., 11, 636, 10.2174/1567201811666140616160237
Yang, 2011, A covalently stabilized lipid-polycation-DNA (sLPD) vector for antisense oligonucleotide delivery, Mol. Pharm., 8, 709, 10.1021/mp100272k
de Wolf, 2007, Effect of cationic carriers on the pharmacokinetics and tumor localization of nucleic acids after intravenous administration, Int. J. Pharm., 331, 167, 10.1016/j.ijpharm.2006.10.029
Foglieni, 2000, Glomerular filtration is required for transfection of proximal tubular cells in the rat kidney following injection of DNA complexes into the renal artery, Gene Ther., 7, 279, 10.1038/sj.gt.3301092
Urbiola, 2013, Efficient serum-resistant lipopolyplexes targeted to the folate receptor, Eur. J. Pharm. Biopharm., 83, 358, 10.1016/j.ejpb.2012.10.012
Nie, 2011, Pyridylhydrazone-based PEGylation for pH-reversible lipopolyplex shielding, Biomaterials, 32, 858, 10.1016/j.biomaterials.2010.09.032
Kurosaki, 2009, Pulmonary gene delivery of hybrid vector, lipopolyplex containing N-lauroylsarcosine, via the systemic route, J. Control. Release, 136, 213, 10.1016/j.jconrel.2009.02.005
Huang, 2013, Targeted delivery of microRNA-29b by transferrin-conjugated anionic lipopolyplex nanoparticles: a novel therapeutic strategy in acute myeloid leukemia, Clin. Cancer Res., 19, 2355, 10.1158/1078-0432.CCR-12-3191
Gonçalves, 2014, Lipopolyplexes comprising imidazole/imidazolium lipophosphoramidate, histidinylated polyethyleneimine and siRNA as efficient formulation for siRNA transfection, Int. J. Pharm., 460, 264, 10.1016/j.ijpharm.2013.11.005
Billiet, 2012, Gene transfer by chemical vectors, and endocytosis routes of polyplexes, lipoplexes and lipopolyplexes in a myoblast cell line, Biomaterials, 33, 2980, 10.1016/j.biomaterials.2011.12.027
Ramezani, 2011, Glactosylated liposome–polyethyleneimine–DNA nanocomplexes as a non-viral vector, Pharmacie Globale (IJCP), 10
Motaharinia, 2011, Liposome-linear polyethyleneimine-DNA nanocomplexes for gene delivery: preparation, characterization and in vitro transfection activity, Curr. Nanosci., 7, 587, 10.2174/157341311796196808
Song, 2012, Cationic lipid-coated PEI/DNA polyplexes with improved efficiency and reduced cytotoxicity for gene delivery into mesenchymal stem cells, Int. J. Nanomedicine, 7, 4637
Jain, 2013, Enhanced transfection efficiency and reduced cytotoxicity of novel lipid–polymer hybrid nanoplexes, Mol. Pharm., 10, 2416, 10.1021/mp400036w
Sabín, 2012, Double charge inversion in polyethylenimine-decorated liposomes, Langmuir, 28, 10534, 10.1021/la3019259
Ma, 2011, Development of a successive targeting liposome with multi-ligand for efficient targeting gene delivery, J. Gene. Med., 13, 290, 10.1002/jgm.1569
Opanasopit, 2011, Type and composition of surfactants mediating gene transfection of polyethylenimine-coated liposomes, Int. J. Nanomedicine, 6, 975, 10.2147/IJN.S18647
Ewe, 2014, Nebulization of liposome–polyethylenimine complexes (lipopolyplexes) for DNA or siRNA delivery: physicochemical properties and biological activity, Eur. J. Lipid Sci. Technol., 116, 1195, 10.1002/ejlt.201300404
Zhou, 1994, DNA transfection mediated by cationic liposomes containing lipopolylysine: characterization and mechanism of action, Biochim. Biophys. Acta, 1189, 195, 10.1016/0005-2736(94)90066-3
Vitiello, 1996, Condensation of plasmid DNA with polylysine improves liposome-mediated gene transfer into established and primary muscle cells, Gene Ther., 3, 396
Golda, 2007, Small poly-l-lysines improve cationic lipid-mediated gene transfer in vascular cells in vitro and in vivo, J. Vasc. Res., 44, 273, 10.1159/000101449
Mockey, 2007, mRNA-based cancer vaccine: prevention of B16 melanoma progression and metastasis by systemic injection of MART1 mRNA histidylated lipopolyplexes, Cancer Gene Ther., 14, 802, 10.1038/sj.cgt.7701072
Perche, 2011, Selective gene delivery in dendritic cells with mannosylated and histidylated lipopolyplexes, J. Drug Target., 19, 315, 10.3109/1061186X.2010.504262
Perche, 2011, Enhancement of dendritic cells transfection in vivo and of vaccination against B16F10 melanoma with mannosylated histidylated lipopolyplexes loaded with tumor antigen messenger RNA, Nanomedicine, 7, 445, 10.1016/j.nano.2010.12.010
Perche, 2012, Gene transfer by histidylated lipopolyplexes: a dehydration method allowing preservation of their physicochemical parameters and transfection efficiency, Int. J. Pharm., 423, 144, 10.1016/j.ijpharm.2011.04.009
Pampinella, 2000, Gene transfer in skeletal muscle by systemic injection of DODAC lipopolyplexes, Neurol. Sci., 21, S967, 10.1007/s100720070011
Turner, 2002, The transfection of Jurkat T-leukemic cells by use of pH sensitive immunoliposomes, J. Liposome Res., 12, 311, 10.1081/LPR-120016197
Lee, 1996, Folate-targeted, anionic liposome-entrapped polylysine-condensed DNA for tumor cell-specific gene transfer, J. Biol. Chem., 271, 8481, 10.1074/jbc.271.14.8481
Anderson, 2004, A polymer library approach to suicide gene therapy for cancer, Proc. Natl. Acad. Sci. U. S. A., 101, 16028, 10.1073/pnas.0407218101
Brito, 2008, Poly(β-amino ester) and cationic phospholipid-based lipopolyplexes for gene delivery and transfection in human aortic endothelial and smooth muscle cells, Biomacromolecules, 9, 1179, 10.1021/bm7011373
Brito, 2008, Gene delivery and transfection studies with lipopolyplexes in human endothelial and smooth muscle cells, 2008, 365
Brito, 2010, In vitro and in vivo studies of local arterial gene delivery and transfection using lipopolyplexes-embedded stents, J. Biomed. Mater. Res. A, 93, 325
Brito, 2010, Non-viral eNOS gene delivery and transfection with stents for the treatment of restenosis, Biomed. Eng. Online, 9, 10.1186/1475-925X-9-56
Su, 2011, In vitro and in vivo mRNA delivery using lipid-enveloped pH-responsive polymer nanoparticles, Mol. Pharm., 8, 774, 10.1021/mp100390w
Oskuee, 2015, A simple approach for producing highly efficient DNA carriers with reduced toxicity based on modified polyallylamine, Mater. Sci. Eng. C Mater. Biol. Appl., 49, 290, 10.1016/j.msec.2015.01.016
Oskuee, 2014, Cationic liposomes–polyallylamine–plasmid nanocomplexes for gene delivery, J. Exp. Nanosci., 9, 1026, 10.1080/17458080.2013.771245
Wang, 2012, Chitosan enhanced gene delivery of cationic liposome via non-covalent conjugation, Biotechnol. Lett., 34, 19, 10.1007/s10529-011-0748-8
Troutier-Thuilliez, 2009, Adsorption of plasmid DNA onto lipid/polymer particle assemblies, Soft Matter, 5, 4739, 10.1039/b911260j
Mastrobattista, 2001, Lipid-coated polyplexes for targeted gene delivery to ovarian carcinoma cells, Cancer Gene Ther., 8, 405, 10.1038/sj.cgt.7700311
Hong, 1997, Stabilization of cationic liposome–plasmid DNA complexes by polyamines and poly(ethylene glycol)–phospholipid conjugates for efficient in vivo gene delivery, FEBS Lett., 400, 233, 10.1016/S0014-5793(96)01397-X
Munye, 2015, Role of liposome and peptide in the synergistic enhancement of transfection with a lipopolyplex vector, Sci. Rep., 5, 10.1038/srep09292
Jain, 2010, Dendrimer toxicity: let's meet the challenge, Int. J. Pharm., 394, 122, 10.1016/j.ijpharm.2010.04.027
Hart, 1998, Lipid-mediated enhancement of transfection by a nonviral integrin-targeting vector, Hum. Gene Ther., 9, 575, 10.1089/hum.1998.9.4-575
Mann, 2008, Peptides in DNA delivery: current insights and future directions, Drug Discov. Today, 13, 152, 10.1016/j.drudis.2007.11.008
Martin, 2007, Peptide-guided gene delivery, AAPS J., 9, E18, 10.1208/aapsj0901003
Schwartz, 1999, Synthetic DNA-compacting peptides derived from human sequence enhance cationic lipid-mediated gene transfer in vitro and in vivo, Gene Ther., 6, 282, 10.1038/sj.gt.3300795
Vaysse, 2000, Transfection using synthetic peptides: comparison of three DNA-compacting peptides and effect of centrifugation, Biochim. Biophys. Acta, 1474, 244, 10.1016/S0304-4165(00)00007-6
Namiki, 1998, Gene transduction for disseminated intraperitoneal tumor using cationic liposomes containing non-histone chromatin proteins: cationic liposomal gene therapy of carcinomatosa, Gene Ther., 5, 240, 10.1038/sj.gt.3300577
Yan, 2011, Biophysical properties and supramolecular structure of self-assembled liposome/ε-peptide/DNA nanoparticles: correlation with gene delivery, Biomacromolecules, 13, 124, 10.1021/bm201359r
Chen, 2000, Co-polymer of histidine and lysine markedly enhances transfection efficiency of liposomes, Gene Ther., 7, 1698, 10.1038/sj.gt.3301294
Fritz, 1996, Gene transfer into mammalian cells using histone-condensed plasmid DNA, Hum. Gene Ther., 7, 1395, 10.1089/hum.1996.7.12-1395
Hagstrom, 1996, Complexes of non-cationic liposomes and histone H1 mediate efficient transfection of DNA without encapsulation, Biochim. Biophys. Acta, 1284, 47, 10.1016/0005-2736(96)00106-X
Hart, 1997, Integrin-mediated transfection with peptides containing arginine–glycine–aspartic acid domains, Gene Ther., 4, 1225, 10.1038/sj.gt.3300513
Kenny, 2012, Multifunctional receptor-targeted nanocomplexes for magnetic resonance imaging and transfection of tumours, Biomaterials, 33, 7241, 10.1016/j.biomaterials.2012.06.042
Hart, 2010, Multifunctional nanocomplexes for gene transfer and gene therapy, Cell Biol. Toxicol., 26, 69, 10.1007/s10565-009-9141-y
Haas, 1994, Integrin–ligarid interactions: a year in review, Curr. Opin. Cell Biol., 6, 656, 10.1016/0955-0674(94)90091-4
Hart, 1995, Gene delivery and expression mediated by an integrin-binding peptide, Gene Ther., 2, 552
Isberg, 1991, Discrimination between intracellular uptake and surface adhesion of bacterial pathogens, Science, 252, 934, 10.1126/science.1674624
Pasqualini, 1995, A peptide isolated from phage display libraries is a structural and functional mimic of an RGD-binding site on integrins, J. Cell Biol., 130, 1189, 10.1083/jcb.130.5.1189
Colin, 1998, Liposomes enhance delivery and expression of an RGD-oligolysine gene transfer vector in human tracheal cells, Gene Ther., 5, 1488, 10.1038/sj.gt.3300760
Jenkins, 2000, An integrin-targeted non-viral vector for pulmonary gene therapy, Gene Ther., 7, 393, 10.1038/sj.gt.3301095
Jenkins, 2003, Formation of LID vector complexes in water alters physicochemical properties and enhances pulmonary gene expression in vivo, Gene Ther., 10, 1026, 10.1038/sj.gt.3301963
Writer, 2004, Targeted gene delivery to human airway epithelial cells with synthetic vectors incorporating novel targeting peptides selected by phage display, J. Drug Target., 12, 185, 10.1080/10611860410001724459
Meng, 2006, Application to vascular adventitia of a nonviral vector for TIMP-1 gene therapy to prevent intimal hyperplasia, Hum. Gene Ther., 17, 717, 10.1089/hum.2006.17.717
Meng, 2013, Inhibition of neointimal hyperplasia in a rabbit vein graft model following non-viral transfection with human iNOS cDNA, Gene Ther., 20, 979, 10.1038/gt.2013.20
Writer, 2012, Lipid peptide nanocomplexes for gene delivery and magnetic resonance imaging in the brain, J. Control. Release, 162, 340, 10.1016/j.jconrel.2012.07.002
Pilkington-Miksa, 2007, Targeting lipopolyplexes using bifunctional peptides incorporating hydrophobic spacer amino acids: synthesis, transfection, and biophysical studies, Bioconjug. Chem., 18, 1800, 10.1021/bc0700943
Tagalakis, 2008, A receptor-targeted nanocomplex vector system optimized for respiratory gene transfer, Mol. Ther., 16, 907, 10.1038/mt.2008.38
Welser, 2013, Gene delivery using ternary lipopolyplexes incorporating branched cationic peptides: the role of peptide sequence and branching, Mol. Pharm., 10, 127, 10.1021/mp300187t
Caracciolo, 2011, Factors determining the superior performance of lipid/DNA/protammine nanoparticles over lipoplexes, J. Med. Chem., 54, 4160, 10.1021/jm200237p
El-Sayed, 2008, Octaarginine-and octalysine-modified nanoparticles have different modes of endosomal escape, J. Biol. Chem., 283, 23450, 10.1074/jbc.M709387200
Hurley, 2008, Mono- and dicationic short PEG and methylene dioxyalkylglycerols for use in synthetic gene delivery systems, Org. Biomol. Chem., 6, 2554, 10.1039/b719702k
Kudsiova, 2011, Lipopolyplex ternary delivery systems incorporating C14 glycerol-based lipids, Mol. Pharm., 8, 1831, 10.1021/mp2001796
Writer, 2006, Analysis and optimization of the cationic lipid component of a lipid/peptide vector formulation for enhanced transfection in vitro and in vivo, J. Liposome Res., 16, 373, 10.1080/08982100600992500
Irvine, 2008, Receptor-targeted nanocomplexes optimized for gene transfer to primary vascular cells and explant cultures of rabbit aorta, Mol. Ther., 16, 508, 10.1038/sj.mt.6300381
Du, 2014, The role of the helper lipid on the DNA transfection efficiency of lipopolyplex formulations, Sci. Rep., 4, 10.1038/srep07107
Wong, 2008, Acid cleavable PEG-lipids for applications in a ternary gene delivery vector, Mol. BioSyst., 4, 532, 10.1039/b719782a
Pilkington-Miksa, 2008, Synthesis of bifunctional integrin-binding peptides containing PEG spacers of defined length for non-viral gene delivery, Eur. J. Org. Chem., 2900, 10.1002/ejoc.200701188
Tagalakis, 2011, Integrin-targeted nanocomplexes for tumour specific delivery and therapy by systemic administration, Biomaterials, 32, 1370, 10.1016/j.biomaterials.2010.10.037
Mustapa, 2009, Stabilized integrin-targeting ternary LPD (lipopolyplex) vectors for gene delivery designed to disassemble within the target cell, Bioconjug. Chem., 20, 518, 10.1021/bc800450r
Grosse, 2010, Tumor-specific gene transfer with receptor-mediated nanocomplexes modified by polyethylene glycol shielding and endosomally cleavable lipid and peptide linkers, FASEB J., 24, 2301, 10.1096/fj.09-144220
Tagawa, 2002, Characterisation of LMD virus-like nanoparticles self-assembled from cationic liposomes, adenovirus core peptide m (mu) and plasmid DNA, Gene Ther., 9, 564, 10.1038/sj.gt.3301686
Bai, 2013, Down-regulated lysosomal processing improved pegylated lipopolyplex-mediated gene transfection, J. Gene Med., 15, 182, 10.1002/jgm.2707